Osteoporosis
From the Journals
Hip T scores can guide duration of osteoporosis therapy
A treat-to-target approach using total hip T scores could help guide decisions about how long women with osteoporosis should stay on bone-building...
News
Romosozumab gets FDA approval for treating osteoporosis
The pair of injections mainly works by encouraging new bone formation.
Conference Coverage
New postmenopausal osteoporosis guidelines emphasize patient priorities
NEW ORLEANS –
News
FDA committee votes yes on romosozumab for osteoporosis
FDA and the sponsor propose postmarketing surveillance to track a questionable cardiovascular safety signal.
From the Journals
Spending on medical marketing increased by $12.2 billion over the last 2 decades
“Although marketing expanded over the 2 decades, regulatory oversight remained relatively limited,” according to the authors.
Commentary
To prevent fractures, treating only women with osteoporosis is not enough
In older osteopenic women, intravenous zoledronic acid effectively prevents fragility fractures.
Clinical Review
2018 Update on bone health
More than one-quarter of women with a hip fracture will be dead within 12 months; maintaining and protecting bone health postmenopause is...
From the Journals
No falls, fractures, or bone density benefits from vitamin D supplements
Vitamin D supplementation does not appear to reduce the risk of falls or fracture or to improve bone mineral density.
Conference Coverage
Zoledronate reduces fracture risk in elderly women with osteopenia
Women with osteopenia who received intravenous zoledronate had a significantly lower risk of fractures.
Drugs, Pregnancy & Lactation
Pregnancy registries are a valuable resource
From the Journals
Breast arterial calcification, low bone mass predict CAD in women
Two commonly performed imaging tests may enhance risk prediction for coronary artery disease in women.